2016
DOI: 10.1158/0008-5472.can-16-0974
|View full text |Cite
|
Sign up to set email alerts
|

Antimetastatic Effect by Targeting CTC Cluster—Response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…Application of the uPA inhibitor for a SCLC model employing human H510 cells, dose-dependently and signi cantly reduced primary tumor growth and numbers of lung metastases [73]. However, the breakdown of CTC clusters by uPA was shown to impair metastasis and reduction of secondary lesions [74][75][76]. Therefore, the CTC cluster-dissociating activity of uPA may outweigh its disease-driving effect under speci c conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Application of the uPA inhibitor for a SCLC model employing human H510 cells, dose-dependently and signi cantly reduced primary tumor growth and numbers of lung metastases [73]. However, the breakdown of CTC clusters by uPA was shown to impair metastasis and reduction of secondary lesions [74][75][76]. Therefore, the CTC cluster-dissociating activity of uPA may outweigh its disease-driving effect under speci c conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Circulating tumor cell (CTC) clusters (composed of two or more tumor cells) have a metastatic advantage over individual CTCs [ 2 , 3 ], which makes them a very clinically relevant population of cells to be targeted. Targeting CTC clusters is considered to be an effective therapeutic strategy [ 4 , 5 ]. However, the underlying mechanisms of the high metastatic capacity of CTC clusters remain to be investigated.…”
Section: Introductionmentioning
confidence: 99%
“…Circulating tumor cell (CTC) clusters (composed of two or more tumor cells) have a metastatic advantage over individual CTCs [2][3], which makes them a very clinically relevant population of cells to target. Targeting CTC clusters is considered to be an effective therapeutic strategy [4][5], however, the underlying mechanisms of the high metastatic capacity of CTC clusters remain to be investigated. The rare number of CTC clusters and the difficulty of capturing them have prevented researchers from obtaining sufficient numbers of CTC clusters for downstream analysis [4], resulting in a very slow development of the molecular biology of CTC clusters.…”
Section: Introductionmentioning
confidence: 99%